B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Sns 314 Mesylate

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Sns 314 Mesylate, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

gw632580x
3 shared targets
bdb
3 shared targets
gw843682x
3 shared targets
bms
5 shared targets
selitrectinib
2 shared targets
naporafenib
2 shared targets
larotrectinib
2 shared targets
tandutinib
7 shared targets
merestinib
3 shared targets
entrectinib
4 shared targets
Loading evidence profile...

This evidence profile for Sns 314 Mesylate is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.